池田健一郎

IKEDA KENICHIRO

所属機関・部署：

研究分野 (1件)：泌尿器科学

競争的資金等の研究課題 (8件)：

2022 - 2026 核移植クローン技術に基づく免疫応答・疾患発症機構の包括的研究基盤
2022 - 2025 ヒトゲノム内在性ウイルス配列によるX精子運動能制御の解明
2021 - 2024 腎細胞癌におけるBACH1機能解析を基礎とした抗PD-1抗体抵抗性獲得機序の解明
2021 - 2024 FGF-FGFR活性化去勢抵抗性前立腺癌オルガノイドの解析による個別化医療の探求
2020 - 2022 扁平上皮分化を伴う浸潤性膀胱癌におけるJAG1の役割の解明

全件表示

論文 (17件)：

Yuki Kohada, Keisuke Goto, Ryo Tasaka, Kensuke Nishida, Kunihiro Hashimoto, Hideo Iwamoto, Tomoya Hatayama, Tomoki Furutani, Shunsuke Miyamoto, Kohei Kobatake, et al. Prognostic Impact of the Modified 5-Item Frailty Index After Radical Nephroureterectomy in Patients With Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study. Clinical genitourinary cancer. 2023
Yuki Kohada, Tetsutaro Hayashi, Kenshiro Takemoto, Syunsuke Miyamoto, Takashi Babasaki, Kohei Kobatake, Hiroyuki Kitano, Kenichiro Ikeda, Keisuke Goto, Keisuke Hieda, et al. The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location. Urology journal. 2023
Yuki Kohada, Keisuke Hieda, Shunsuke Miyamoto, Ryo Tasaka, Akihiro Asami, Kosuke Akiyama, Yuki Sakamoto, Fumiaki Kirishima, Kohei Saito, Takafumi Fukushima, et al. Retrospective evaluation of the improvement in the urinary status-related quality of life after robot-assisted radical prostatectomy. International journal of urology : official journal of the Japanese Urological Association. 2023
Yuki Kohada, Takashi Babasaki, Keisuke Goto, Shogo Inoue, Yoshimasa Kurimura, Ryo Tasaka, Kenshiro Takemoto, Shunsuke Miyamoto, Kohei Kobatake, Hiroyuki Kitano, et al. Long-term efficacy of penile rehabilitation with low-intensity extracorporeal shock wave therapy for sexual and erectile function recovery following robotic-assisted radical prostatectomy: a single-cohort pilot study. Sexual medicine. 2023. 11. 2. qfad023
Kenshiro Takemoto, Kohei Kobatake, Kento Miura, Takafumi Fukushima, Takashi Babasaki, Shunsuke Miyamoto, Yohei Sekino, Hiroyuki Kitano, Keisuke Goto, Kenichiro Ikeda, et al. BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress-related tumorigenicity. Cancer science. 2022. 114. 2. 436-448

MISC (4件)：

Tetsutaro Hayashi, Keisuke Goto, Yukiko Honda, Ryan Hsi, Kazuhiro Sentani, Kenichiro Ikeda, Yuki Kohada, Shogo Inoue, Jun Teishima, Wataru Yasui, et al. ACCURATE CLINICAL T3 STAGING BY A COMPUTED TOMOGRAPHY SCORING SYSTEM IS AN INDEPENDENT PREOPERATIVE PREDICTOR OF SURVIVAL IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE URETER. JOURNAL OF UROLOGY. 2020. 203. E524-E524
Kohei Kobatake, Kenichiro Ikeda, Yuichiro Nakata, Norimasa Yamasaki, Takeshi Ueda, Akinori Kanai, Kazuhiro Sentani, Yasuyuki Sera, Tetsutaro Hayashi, Miho Koizumi, et al. Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization, and causes bladder cancer in cooperation with p53 dysfunction. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020. 26. 8. 2065-2079
Yuichiro Nakata, Norimasa Yamasaki, Takeshi Ueda, Kenichiro Ikeda, Akiko Nagamachi, Toshiya Inaba, Hiroaki Honda. JMJD3 Plays Essential Roles in the Maintenance of Hematopoietic Stem Cells and Leukemic Stem Cells through the Regulation of p16(INK4a). BLOOD. 2016. 128. 22
Kenichiro Ikeda, Jun Teishima, Tetsutaro Hayashi, Keisuke Goto, Akihiro Goriki, Kouji Arihiro, Kazuhiro Sentani, Wataru Yasui, Akio Matsubara. CATAMNESTIC FOLLOW-UP OF RENAL CELL CARCINOMAS AMONG ATOMIC BOMB SURVIVORS ACCORDING TO RADIATION EXPOSURE STATUS. JOURNAL OF UROLOGY. 2012. 187. 4. E292-E292

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

池田 健一郎

池田健一郎